CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Early use of Empagliflozin (JARDIANCE) in the full spectrum of HF

Document ID: PC-PH-104058

06/12/2022

Author: Boehringer Ingelheim

Related content

 
PC-PH-104058
Production date: December 2022